Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Primary Immune Regulatory Disorders (PIRDs) That Amplify mTOR Signaling Share a T Cell Exhaustion-like Process

Peyton E Conrey, Jose Campos, Andrea Mauracher, Samir Sayed, Jolan E. Walter, Helen Su, Sara Barmettler, Jennifer W Leiding, Megan Cooper, Suzanne P MacFarland, Melanie A Ruffner, Jocelyn R Farmer, V. Koneti Rao, Sarah E Henrickson

Blood (2023) 142 (Supplement 1): 2555.

https://doi.org/10.1182/blood-2023-188195

Published: 2023

Journal Articles

Clinical Spectrum of Patients with Pathogenic Variant of STAT3 conferring Gain-of-Function: A Mimic of Autoimmune Lymphoproliferative Syndrome

Gregory Constantine, MD, Helen Su, MD, PhD, Les Folio, MD, Joshua Milner, MD, V. Koneti Rao, MD FRCPA

Blood (2018) 132 (Supplement 1): 3723.

https://doi.org/10.1182/blood-2018-99-111950

Published: 2018

Journal Articles

Haploidentical Transplantation for DOCK8 Deficiency

Nirali N Shah, MD, Alexandra F Freeman, MD, Mark Parta, MD, Helen Su, MD PhD, Gulbu Uzel, MD, Juan C. Gea-Banacloche, MD, Steven M. Holland, MD, Dennis D. Hickstein, MD

Blood (2015) 126 (23): 2229.

https://doi.org/10.1182/blood.V126.23.2229.2229

Published: 2015

Journal Articles

XMEN disease: a new primary immunodeficiency affecting Mg 2+ regulation of immunity against Epstein-Barr virus

Feng-Yen Li, Benjamin Chaigne-Delalande, Helen Su, Gulbu Uzel, Helen Matthews, Michael J. Lenardo

Blood (2014) 123 (14): 2148–2152.

https://doi.org/10.1182/blood-2013-11-538686

Published: 2014

Journal Articles

A Novel Gain-Of-Function Mutation In The CARD Domain Of CARD11 (C49Y) Results In Benta Disease

David K. Buchbinder, MD, MSHS, Jeffrey R. Stinson, Diane J. Nugent, MD, Helen Su, MD, PhD, Clifton Dalgard, Gauthaman Sukumar, Yu Zhang, Andrew Linnell Snow, PhD

Blood (2013) 122 (21): 3485.

https://doi.org/10.1182/blood.V122.21.3485.3485

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency

Jennifer Cuellar-Rodriguez, M.D., Alexandra F Freeman, MD, Juan Gea-Banacloche, MD, Helen Su, MD, PHD, Jennifer K. Grossman, MD, BSc, Terry J Fry, MD, Steven M. Holland, MD, Dennis D. Hickstein, M.D.

Blood (2013) 122 (21): 2114.

https://doi.org/10.1182/blood.V122.21.2114.2114

Published: 2013

Journal Articles

Overexpression of murine fizzy-related (fzr) increases natural killer cell–mediated cell death and suppresses tumor growth

Chun-Xiang Wang, Bernard C. Fisk, Madhuri Wadehra, Helen Su, Jonathan Braun

Blood (2000) 96 (1): 259–263.

https://doi.org/10.1182/blood.V96.1.259

Published: 2000

NARROW

Primary Immune Regulatory Disorders (PIRDs) That Amplify mTOR Signaling Share a T Cell Exhaustion-like Process

Clinical Spectrum of Patients with Pathogenic Variant of STAT3 conferring Gain-of-Function: A Mimic of Autoimmune Lymphoproliferative Syndrome

Haploidentical Transplantation for DOCK8 Deficiency

XMEN disease: a new primary immunodeficiency affecting Mg 2+ regulation of immunity against Epstein-Barr virus

A Novel Gain-Of-Function Mutation In The CARD Domain Of CARD11 (C49Y) Results In Benta Disease

Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency

Overexpression of murine fizzy-related (fzr) increases natural killer cell–mediated cell death and suppresses tumor growth

Email alerts

ASH Publications

American Society of Hematology

Primary Immune Regulatory Disorders (PIRDs) That Amplify mTOR Signaling Share a T Cell Exhaustion-like Process

Clinical Spectrum of Patients with Pathogenic Variant of STAT3 conferring Gain-of-Function: A Mimic of Autoimmune Lymphoproliferative Syndrome

Haploidentical Transplantation for DOCK8 Deficiency

XMEN disease: a new primary immunodeficiency affecting Mg 2+ regulation of immunity against Epstein-Barr virus

A Novel Gain-Of-Function Mutation In The CARD Domain Of CARD11 (C49Y) Results In Benta Disease

Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency

Overexpression of murine fizzy-related (fzr) increases natural killer cell–mediated cell death and suppresses tumor growth

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only